Elicio Therapeutics Stock (NASDAQ: ELTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 50.62K |
Day Range | - - - |
52 Wk Range | 2.96 - 11.45 |
Market Cap | $50.51M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 0.79% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Elicio Therapeutics (NASDAQ:ELTX) through any online brokerage.
Other companies in Elicio Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and CARISMA Therapeutics (NASDAQ:CARM).
There is no analysis for Elicio Therapeutics.
Elicio Therapeutics has a consensus price target of $10.00.
The stock price for Elicio Therapeutics (NASDAQ: ELTX) is $4.69 last updated July 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Elicio Therapeutics.
Elicio Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Elicio Therapeutics.
Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.